LifeStance Health Group DEF 14A Filing
Ticker: LFST · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1845257
| Field | Detail |
|---|---|
| Company | Lifestance Health Group, Inc. (LFST) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
Related Tickers: LFST
TL;DR
LifeStance Health's DEF 14A is out, showing exec comp details for 2023. Look out for Kenneth Burdick's equity awards.
AI Summary
LifeStance Health Group, Inc. filed a DEF 14A on April 23, 2025, detailing executive compensation for the fiscal year ending December 31, 2023. The filing includes information on stock awards and option awards granted to individuals such as Kenneth Burdick, with specific dates and values related to vesting and outstanding equity awards.
Why It Matters
This filing provides transparency into how LifeStance Health compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy statement filing detailing executive compensation and corporate governance matters.
Key Numbers
- 2023 — Fiscal Year End (The period for which executive compensation is detailed.)
- 20250423 — Filing Date (The date the DEF 14A was submitted to the SEC.)
Key Players & Entities
- LifeStance Health Group, Inc. (company) — Filer of the DEF 14A
- Kenneth Burdick (person) — Executive mentioned in relation to equity awards
- 0000950170-25-057496 (filing_id) — Accession number for the filing
- 20250423 (date) — Filing date
- 2023-12-31 (date) — Fiscal year end for compensation details
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding the company's annual meeting, including details on executive compensation, director nominations, and other corporate governance matters.
Who is Kenneth Burdick and what is his role in relation to the compensation details?
Kenneth Burdick is identified as a member (Member) of the company, and the filing details his equity awards, including stock and option awards, for the fiscal years ending December 31, 2022, and 2023.
What types of compensation are detailed in the filing?
The filing details stock awards and option awards, including changes in their fair value, vesting dates, and year-end values for outstanding and unvested equity.
What is the fiscal year end for the compensation data presented?
The compensation data presented in the filing pertains to the fiscal year ending December 31, 2023, with comparative data from prior years like 2022 and 2021.
What is the filing date of this DEF 14A?
This DEF 14A filing was made on April 23, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 by Kenneth Burdick regarding LifeStance Health Group, Inc. (LFST).